Genesis Biopharma

Genesis Biopharma names Bishop executive chairman

Friday, March 23, 2012 03:12 PM

Genesis Biopharma, a biotechnology company developing targeted cancer immunotherapies, appointed Hans E. Bishop executive chairman of the company's board of directors.

More... »


Genesis names Voyticky to board of directors

Wednesday, July 20, 2011 11:50 AM

Genesis Biopharma has named David Voyticky to its board of directors. Voyticky is currently president of Miller Energy Resources, an oil and gas exploration company, and has more than 16 years of experience in corporate finance and merger and acquisition consulting.

More... »


Radvanyi joins Genesis Biopharma

Wednesday, July 6, 2011 10:19 AM

Genesis Biopharma, a biotechnology company developing targeted cancer therapies, has named Laszlo Radvanyi, Ph.D., to its Scientific and Medical Advisory Board.

More... »

Patrick Hwu and Mario Sznol join Genesis Biopharma's advisory board

Friday, May 27, 2011 12:07 PM

Genesis Biopharma, a biotechnology company developing targeted cancer therapies, note that Patrick Hwu, M.D., and Mario Sznol, M.D., have joined the company's recently formed scientific and medical advisory board.

More... »

Genesis Biopharma names L. Stephen Coles to board of directors

Tuesday, March 1, 2011 08:00 AM

Genesis Biopharma, a biotechnology company developing targeted cancer therapies, has appointed L. Stephen Coles, M.D., Ph.D., to the company's board of directors. 

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs